Guan Xuechun, Lan Qiaoqing, Liang Yi, Ke Honghong, Chen Siqi, Long Liling
Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Front Cardiovasc Med. 2022 Feb 25;9:846805. doi: 10.3389/fcvm.2022.846805. eCollection 2022.
We compared the efficacy of single phase-computed tomography pulmonary angiography (SP-CTPA) and dual phase-computed tomography pulmonary angiography (DP-CTPA) for the diagnosis of pulmonary embolism (PE).
We recruited 1,019 consecutive patients (359 with PE) who underwent DP-CTPA (phase I: pulmonary artery phase; phase II: aortic phase) for suspected PE between January and October 2021. Phase I of DP-CTPA was used as SP-CTPA, and the final clinical diagnosis (FCD) was used as the gold standard.
Three hundred fifty-two cases of PE were detected by both methods, with the same sensitivity of 98.1% (99.6-99.5%). Using SP-CTPA, 142 cases [13 pulmonary insufficiency artifacts (PIA) and 129 systemic-pulmonary shunt artifacts (S-PSA)] were false-positive with specificity of 78.5% (75.3-81.6%). No false-positive was found with DP-CTPA, with specificity of 100%, positive predictive value of 1, and negative predictive value of 0.990 (Net Reclassification Improvement = 0.215; < 0.05). According to FCD, the positive results of SP-CTPA were divided into PIA, S-PSA, and true-positive (TP) groups, and pairwise comparisons were performed. The bronchiectasis and hemoptysis rate in S-PSA group was higher than that in PIA and TP groups ( < 0.001), and the pulmonary hypertension (PH) rate in PIA group was higher than that in S-PSA and TP groups ( < 0.001).
The diagnostic efficiency of DP-CTPA for the diagnosis of PE was high. SP-CTPA may misdiagnose PIA (common in patients with PH) and S-PSA (common in patients with bronchiectasis and hemoptysis) as PE.
比较单相计算机断层扫描肺动脉造影(SP-CTPA)和双相计算机断层扫描肺动脉造影(DP-CTPA)在诊断肺栓塞(PE)方面的疗效。
我们招募了1019例连续患者(359例患有PE),这些患者在2021年1月至10月期间因疑似PE接受了DP-CTPA检查(第一阶段:肺动脉期;第二阶段:主动脉期)。DP-CTPA的第一阶段用作SP-CTPA,最终临床诊断(FCD)用作金标准。
两种方法均检测出352例PE,灵敏度相同,均为98.1%(99.6 - 99.5%)。使用SP-CTPA时,142例[13例肺功能不全伪影(PIA)和129例体肺分流伪影(S-PSA)]为假阳性,特异性为78.5%(75.3 - 81.6%)。DP-CTPA未发现假阳性,特异性为100%,阳性预测值为1,阴性预测值为0.990(净重新分类改善 = 0.215;<0.05)。根据FCD,将SP-CTPA的阳性结果分为PIA、S-PSA和真阳性(TP)组,并进行两两比较。S-PSA组的支气管扩张和咯血发生率高于PIA组和TP组(<0.001),PIA组肺动脉高压(PH)发生率高于S-PSA组和TP组(<0.001)。
DP-CTPA对PE的诊断效率较高。SP-CTPA可能将PIA(常见于PH患者)和S-PSA(常见于支气管扩张和咯血患者)误诊为PE。